GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹699 Cr | ₹812 Cr | ₹809 Cr | ₹1,248 Cr | ₹4,445 Cr |
What is the latest Total Non-Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Non-Current Assets |
---|---|
Mar2023 | ₹699 Cr |
Mar2022 | ₹812 Cr |
Mar2021 | ₹809 Cr |
Mar2020 | ₹1,248 Cr |
Mar2019 | ₹4,445 Cr |
How is Total Non-Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹699 Cr | -13.95 | |
Mar2022 | ₹812 Cr | 0.40 | |
Mar2021 | ₹809 Cr | -35.18 | |
Mar2020 | ₹1,248 Cr | -71.93 | |
Mar2019 | ₹4,445 Cr | - |
Compare Total Non-Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹38,818.9 Cr | 14.7% | 20.6% | 58.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | 0.4% | -0.4% | 61.2% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | -1.1% | 1.7% | 53.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 5.9% | 11.3% | 94.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | -0.1% | 3.9% | 20% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -2% | -4.2% | 29.3% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 14.7% |
20.6% |
58.1% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses